| Cancer-related Molecular Pathways | Lifetime | 106 | CN 5 | 99.48 |
| Tea Polyphenols and Effects | Lifetime | 33 | CN 7 | 99.11 |
| Genomics, phytochemicals, and oxidative stress | Lifetime | 64 | CN 1 | 99.04 |
| Retinoids in leukemia and cellular processes | Lifetime | 70 | CN 1 | 99.03 |
| Cancer Mechanisms and Therapy | Lifetime | 87 | CN 6 | 98.90 |
| Melanoma and MAPK Pathways | Lifetime | 78 | CN 3 | 99.04 |
| Ubiquitin and proteasome pathways | Lifetime | 268 | CN 17 | 98.68 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 199 | CN 5 | 98.70 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 86 | CN 10 | 97.84 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 245 | CN 9 | 97.87 |
| Bioactive Compounds and Antitumor Agents | Lifetime | 256 | CN 11 | 97.05 |
| NF-κB Signaling Pathways | Lifetime | 334 | CN 21 | 96.82 |
| Tannin, Tannase and Anticancer Activities | Lifetime | 39 | CN 5 | 96.54 |
| Skin Protection and Aging | Lifetime | 400 | CN 3 | 96.56 |
| Inflammatory mediators and NSAID effects | Lifetime | 818 | CN 26 | 95.86 |
| Cell death mechanisms and regulation | Lifetime | 703 | CN 42 | 95.50 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 626 | CN 14 | 96.09 |
| melanin and skin pigmentation | Lifetime | 703 | CN 24 | 94.06 |
| Bioactive natural compounds | Lifetime | 278 | CN 41 | 92.60 |
| Signaling Pathways in Disease | Lifetime | 893 | CN 51 | 92.55 |
| FOXO transcription factor regulation | Lifetime | 258 | CN 39 | 89.08 |
| Morinda citrifolia extract uses | Lifetime | 329 | CN 47 | 79.19 |
| Ginger and Zingiberaceae research | Lifetime | 830 | CN 132 | 79.34 |
| Hops Chemistry and Applications | Lifetime | 469 | CN 11 | 70.37 |
| Magnolia and Illicium research | Lifetime | 816 | CN 321 | 42.73 |
| Cancer Mechanisms and Therapy | 2021-2025 | 22 | CN 8 | 97.65 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 360 | CN 61 | 97.63 |
| Cancer-related Molecular Pathways | 2021-2025 | 70 | CN 9 | 94.95 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 68 | CN 8 | 92.30 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 238 | CN 46 | 80.79 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 229 | CN 13 | 71.23 |
| FOXO transcription factor regulation | 2021-2025 | 166 | CN 55 | 60.41 |
| Heat shock proteins research | 2021-2025 | 805 | CN 182 | 52.56 |
